(1) an overdose outreach provider may: (a) obtain an opiate antagonist dispensed on prescription by: (i) a health care provider, in accordance with Subsections 26-55-104(2) and (3); or (ii) a pharmacist or pharmacy intern, as otherwise authorized by Title 58, Chapter 17b, Pharmacy Practice Act; (b) store the opiate antagonist; and (c) furnish the opiate antagonist: (i) (A) to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or (B) to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and (ii) without liability for any civil damages for acts or omissions made as a result of furnishing the opiate antagonist in good faith; and
(a) obtain an opiate antagonist dispensed on prescription by: (i) a health care provider, in accordance with Subsections 26-55-104(2) and (3); or (ii) a pharmacist or pharmacy intern, as otherwise authorized by Title 58, Chapter 17b, Pharmacy Practice Act;
(i) a health care provider, in accordance with Subsections 26-55-104(2) and (3); or
(ii) a pharmacist or pharmacy intern, as otherwise authorized by Title 58, Chapter 17b, Pharmacy Practice Act;
(b) store the opiate antagonist; and
(c) furnish the opiate antagonist: (i) (A) to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or (B) to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and (ii) without liability for any civil damages for acts or omissions made as a result of furnishing the opiate antagonist in good faith; and
(i) (A) to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or (B) to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and
(A) to an individual who is at increased risk of experiencing an opiate-related drug overdose event; or
(B) to a family member, friend, overdose outreach provider, or other individual who is in a position to assist an individual who is at increased risk of experiencing an opiate-related drug overdose event; and
(ii) without liability for any civil damages for acts or omissions made as a result of furnishing the opiate antagonist in good faith; and
(2) when furnishing an opiate antagonist under Subsection (1), an overdose outreach provider: (a) shall also furnish to the recipient of the opiate antagonist: (i) the written instruction under Subsection 26-55-104(3) received by the overdose outreach provider from the health care provider at the time the opiate antagonist was dispensed to the overdose outreach provider; or (ii) if the opiate antagonist was dispensed to the overdose outreach provider by a pharmacist or pharmacy intern, any written patient counseling under Section 58-17b-613 received by the overdose outreach provider at the time of dispensing; and (b) may provide additional instruction on how to recognize and respond appropriately to an opiate-related drug overdose event.
(a) shall also furnish to the recipient of the opiate antagonist: (i) the written instruction under Subsection 26-55-104(3) received by the overdose outreach provider from the health care provider at the time the opiate antagonist was dispensed to the overdose outreach provider; or (ii) if the opiate antagonist was dispensed to the overdose outreach provider by a pharmacist or pharmacy intern, any written patient counseling under Section 58-17b-613 received by the overdose outreach provider at the time of dispensing; and
(i) the written instruction under Subsection 26-55-104(3) received by the overdose outreach provider from the health care provider at the time the opiate antagonist was dispensed to the overdose outreach provider; or
(ii) if the opiate antagonist was dispensed to the overdose outreach provider by a pharmacist or pharmacy intern, any written patient counseling under Section 58-17b-613 received by the overdose outreach provider at the time of dispensing; and
(b) may provide additional instruction on how to recognize and respond appropriately to an opiate-related drug overdose event.
Copyright ©2024 LegalFix. All rights reserved. LegalFix is not a law firm, is not licensed to practice law, and does not provide legal advice, services, or representation. The information on this website is an overview of the legal plans you can purchase—or that may be provided by your employer as an employee benefit or by your credit union or other membership group as a membership benefit.
LegalFix provides its members with easy access to affordable legal services through a network of independent law firms. LegalFix, its corporate entity, and its officers, directors, employees, agents, and contractors do not provide legal advice, services, or representation—directly or indirectly.
The articles and information on the site are not legal advice and should not be relied upon—they are for information purposes only. You should become a LegalFix member to get legal services from one of our network law firms.
You should not disclose confidential or potentially incriminating information to LegalFix—you should only communicate such information to your network law firm.
The benefits and legal services described in the LegalFix legal plans are not always available in all states or with all plans. See the legal plan Benefit Overview and the more comprehensive legal plan contract during checkout for coverage details in your state.
Use of this website, the purchase of legal plans, and access to the LegalFix networks of law firms are subject to the LegalFix Terms of Service and Privacy Policy.